OpenLegislation

Article 8 F1F2

United Kingdom

Original text. Later amendments are not shown.

1.

When the scheduled substances are entered into F3Great Britain for unloading or transhipment, for temporary storage, for their storage in a free zone F4..., or for their placing under the external Union transit procedure, the licit purposes must be demonstrated by the operator, upon request by the competent authorities.

2.

F5The Secretary of State may make regulations to establish the criteria to determine how the licit purposes of the transaction may be demonstrated, in order to ensure that all movements of scheduled substances within F6Great Britain can be monitored by the competent authorities and the risk of diversion be minimised.

Annotations

Textual amendments

F1

Regulation revoked (N.I.) (29.6.2026) by The Controlled Drugs (Drug Precursors) (Amendment and Revocation) Regulations 2026 (S.I. 2026/607), reg. 1(1), Sch.

F2

Substituted by Regulation (EU) No 1259/2013 of the European Parliament and of the Council of 20 November 2013 amending Council Regulation (EC) No 111/2005 laying down rules for the monitoring of trade between the Community and third countries in drug precursors.

F3

Words in Art. 8(1) substituted (29.6.2026) by The Controlled Drugs (Drug Precursors) (Amendment and Revocation) Regulations 2026 (S.I. 2026/607), regs. 1(1), 6(6)

F4

Words in Art. 8(1) omitted (31.12.2020) by virtue of The Law Enforcement and Security (Amendment) (EU Exit) Regulations 2019 (S.I. 2019/742), regs. 1, 14(6)(a)(ii); 2020 c. 1, Sch. 5 para. 1(1)

F5

Words in Art. 8(2) substituted (31.12.2020) by The Law Enforcement and Security (Amendment) (EU Exit) Regulations 2019 (S.I. 2019/742), regs. 1, 14(6)(b)(i); 2020 c. 1, Sch. 5 para. 1(1)

F6

Words in Art. 8(2) substituted (29.6.2026) by The Controlled Drugs (Drug Precursors) (Amendment and Revocation) Regulations 2026 (S.I. 2026/607), regs. 1(1), 6(6)